PROLASTIN subst sèche 1 g c solv incl Mix2Vial set

7680006970021 CH-697 B02AB02 06.01.1.
PROLASTIN subst sèche 1 g c solv incl Mix2Vial set
PROLASTIN subst sèche 1 g c solv incl Mix2Vial set
PROLASTIN subst sèche 1 g c solv incl Mix2Vial set
1 / 3
google

Details

Product number
0069701
CPT
-
Packaging group
1
Unit
Set
Composition
Praeparatio cryodesiccata: alpha-1-proteinasi inhibitor humanum 1 g, natrii chloridum, natrii dihydrogenophosphas, pro vitro corresp. natrium 110 mg. Solvens: aqua ad iniectabile.

Articles (1)

Prolastin, poudre et solvant pour solution pour perfusion
Puder
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
08/02/2025
Professional SmPC
Français
08/02/2025
Professional SmPC
Italien
08/02/2025

Detailed composition

Substance Quantity Type Category
SOLV
- Substance HNIDK
PRC
1.0 G Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
110.0 MG Substance HBESI

Reimbursement information

Public price
CHF 361.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2012

Authorization holder

OM Pharma Suisse SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
697
Drug name
Prolastin, poudre et solvant pour solution pour perfusion
Galenic form
LSPA
ATC Code
B02AB02
Authorization status
Z
Dispensation category
B
First authorization
19/01/2006
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Dauersubstitution bei Alpha-1-Proteinaseninhibitormangel mit progredientem Lungenemphysem bei Patienten mit Proteinaseninhibitor-Phänotyp (Z,Z), (Z,Null), (Null,Null) oder (S,Z)

Packaging details

Description (FR)
PROLASTIN subst sèche 1 g c solv incl Mix2Vial set
Description (DE)
PROLASTIN Trockensub 1 g c Solv inkl Mix2Vial Set
Market launch
19/01/2006
Narcotic (BTM)
No

Application methods

IV

Other packaging sizes